scientist at nova southeastern university, United States
Dr. Anusha Thumma holds a Ph.D. in Pharmaceutical Sciences and specializes in drug formulation, abuse-deterrent technologies, inhalation products, and vaccine adjuvants. With expertise in HPLC, qPCR, ELISA, DSC, and flow cytometry, she ensures regulatory compliance with FDA, ICH, GMP, and GLP standards. She has worked as an Associate Scientist at Lupin Pharmaceuticals, an R&D Scientist at US Pharma LTD, and an Associate Professor at Radex Regulatory Affairs. Her research includes mRNA vaccine lipid nanoparticles and opioid abuse-deterrent formulations. She excels in project management, data analysis (Minitab), and cross-functional collaboration.
Publication Profile
Orcid
🎓 Education
Dr. Anusha Thumma holds a Doctor of Philosophy (PhD) in Pharmaceutical Sciences from Nova Southeastern University, USA (2023), where her dissertation focused on Abuse-Deterrent Composites: A Multi-Angle Approach. She earned her Master of Pharmacy (MPharm) from Osmania University, India (2013), specializing in Formulation and Characterization of Imiquimod Multiple Emulsion as a Novel Vaccine Delivery System. Her academic journey began with a Bachelor of Pharmacy (BPharm) from Kakatiya University, India (2011). With a strong foundation in pharmaceutical sciences, her research contributions span drug formulation, regulatory affairs, and vaccine development. 💊🔬
🏆 Academic Excellence & Professional Achievements
Dr. Anusha Thumma has been recognized with multiple prestigious scholarships and grants for her outstanding academic and research contributions. She received a fully funded PhD scholarship and a PhD Scholar Stipend from Nova Southeastern University, USA, along with the President’s Faculty Research and Development Grant and HPD Research Grant for her research excellence. She also secured fully funded scholarships for her Master’s (Osmania University) and Bachelor’s (Kakatiya University) degrees in India. Additionally, she holds a Professional Diploma in Regulatory Affairs (USA), is a Registered Pharmacist (India), and has attended webinars on drug discovery. 📜🎓💊
🔬 Research Focus Areas
Dr. Anusha Thumma’s research primarily focuses on environmental remediation 🌱, pharmaceutical sciences 💊, and drug abuse potential 🧪. She has made significant contributions to water purification by exploring biochar-based adsorption for removing heavy metals (cadmium, zinc, arsenic) and dyes from polluted water. Her expertise extends to pharmaceutical formulations, particularly in abuse-deterrent drug delivery systems. Additionally, she investigates the toxicity and abuse potential of fentanyl analogues. Her interdisciplinary work integrates biopolymer-based cryostructures, advancing biomedical and pharmaceutical applications. Through her research, she aims to enhance sustainable environmental solutions and safer pharmaceutical formulations. 🌍🔬💧
Publication Top Notes
- Adsorptive removal of arsenic from drinking water using KOH-modified sewage sludge-derived biochar
-
Exploring the efficiency of sodium alginate beads and Cedrus deodara sawdust for adsorptive removal of crystal violet dye
-
Advances in cryostructures and their applications in biomedical and pharmaceutical products
-
Abuse potential of fentanyl and fentanyl analogues
-
Removal of cadmium and zinc from water using sewage sludge-derived biochar
-
Potential of easily available low-cost raw cotton for the elimination of methylene blue dye from polluted water